Article ; Online: Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis.
Journal of medicinal chemistry
2024 Volume 67, Issue 5, Page(s) 3571–3589
Abstract: PAR4 is a promising antithrombotic target with potential for separation of efficacy from bleeding risk relative to current antiplatelet therapies. In an effort to discover a novel PAR4 antagonist chemotype, a quinoxaline-based HTS ... ...
Abstract | PAR4 is a promising antithrombotic target with potential for separation of efficacy from bleeding risk relative to current antiplatelet therapies. In an effort to discover a novel PAR4 antagonist chemotype, a quinoxaline-based HTS hit |
---|---|
MeSH term(s) | Animals ; Fibrinolytic Agents/pharmacology ; Fibrinolytic Agents/therapeutic use ; Macaca fascicularis ; Quinoxalines/pharmacology ; Quinoxalines/therapeutic use ; Receptors, Thrombin ; Thrombin ; Hemorrhage ; Thrombosis/drug therapy ; Thrombosis/prevention & control ; Receptor, PAR-1 ; Blood Platelets ; Platelet Aggregation |
Chemical Substances | protease-activated receptor 4 (JWE1M73YZN) ; Fibrinolytic Agents ; Quinoxalines ; Receptors, Thrombin ; Thrombin (EC 3.4.21.5) ; Receptor, PAR-1 |
Language | English |
Publishing date | 2024-02-22 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 218133-2 |
ISSN | 1520-4804 ; 0022-2623 |
ISSN (online) | 1520-4804 |
ISSN | 0022-2623 |
DOI | 10.1021/acs.jmedchem.3c01986 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 151: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MB 1: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.